Superworth

Calidi Biotherapeutics market cap CLDI

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$1.7M
Highest close in our data
$290.8M
Sep 2022

Calidi Biotherapeutics is worth $1.7M at the close on Nov 2, 2026, at $0.66 a share.

That is down 65% over the last year and down 99% over five years.

Its highest close in our data was $290.8M in Sep 2022.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$1.7M$1.6M$8.5M−81%
2025$8.9M$4.9M$24.2M−49%
2024$17.5M$5.7M$51.7M−67%
2023$53.5M$19.3M$104.1M−47%
2022$100.5M$98.7M$290.8M−64%
2021$282M$282M$283.2Mn/a

Against its peers

Companies in Healthcare nearest Calidi Biotherapeutics' size, closest first, today.

CompanyMarket cap
CLDICalidi Biotherapeutics$1.7M
OXBROXBRIDGE RE HOLDINGS$6.5M
EDUCEducational Development$8.9M
GTIMGood Times Restaurants$14M
Peer median$8.9M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Calidi Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.